Cargando…
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
BACKGROUND: The last international consensus on the management of type 2 diabetes (T2D) recommends SGLT-2 inhibitors or GLP-1 agonists for patients with clinical cardiovascular (CV) disease; metformin remains the first-line glucose lowering medication. Last studies suggested beneficial effects of SG...
Autores principales: | Grenet, Guillaume, Ribault, Shams, Nguyen, Giao Bao, Glais, Faustine, Metge, Augustin, Linet, Thomas, Kassai-Koupai, Behrouz, Cornu, Catherine, Bejan-Angoulvant, Théodora, Erpeldinger, Sylvie, Boussageon, Rémy, Gouraud, Aurore, Bonnet, Fabrice, Cucherat, Michel, Moulin, Philippe, Gueyffier, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592598/ https://www.ncbi.nlm.nih.gov/pubmed/31237921 http://dx.doi.org/10.1371/journal.pone.0217701 |
Ejemplares similares
-
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review
por: Boussageon, Rémy, et al.
Publicado: (2013) -
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
por: Boussageon, Rémy, et al.
Publicado: (2011) -
Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials
por: Boussageon, Rémy, et al.
Publicado: (2012) -
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
por: Erpeldinger, Sylvie, et al.
Publicado: (2016) -
Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality
por: Erpeldinger, Sylvie, et al.
Publicado: (2013)